Tickwind
TodayOpportunitiesMarketsAI Chat
EN
Log inSign up
Tickwind

Read every tick. See where the market's blowing.

  • X
  • TelegramChinese
  • Newsletter

Product

  • Markets
  • Theme Zones
  • All stocks
  • Compare
  • Hot stocks
  • Opportunities
  • News
  • Discussion
  • Watchlist
  • What's new

Account

  • Settings
  • Newsletter
  • For writers
  • MCP server
  • Contact
  • Log in
  • Sign up
MarketsTheme ZonesAll stocksCompareHot stocksOpportunitiesNewsDiscussionWatchlistWhat's newSettingsNewsletterFor writersMCP serverContactLog inSign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

Home/DMAAU/Operating cash flow

DRUGS MADE IN AMERICA ACQUISITION CORP. (DMAAU) Operating cash flow

DRUGS MADE IN AMERICA ACQUISITION CORP. (DMAAU) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.

-$539,187FY2025
25
Fiscal yearValueYoY
FY2025-$539,187—

Source: SEC XBRL filings · For reference only · Not investment advice

More DMAAU financial trends

DMAAU RevenueDMAAU Net incomeDMAAU Net marginDMAAU Gross profitDMAAU Gross marginDMAAU Operating incomeDMAAU Operating marginDMAAU Free cash flowDMAAU Capital expendituresDMAAU Return on equityDMAAU Stock buybacksDMAAU Dividends paidDMAAU Total assetsDMAAU Total liabilitiesDMAAU Shareholders’ equityDMAAU overview →